CMPX · Compass Therapeutics, Inc. · Documents
$0.86
+0.02 (+2.60%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$150.37M
Shares
180.09M
Volume · Oct 20
315.75K
Avg daily vol (3M)
4.28M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-04-24 | 2023-04-21 | |
| 10-K | — | 2023-03-15 | 2022-12-31 | |
| 8-K | — | 2023-03-10 | — | |
| 8-K | — | 2023-02-24 | 2023-02-20 | |
| 8-K | — | 2023-02-10 | 2023-02-08 | |
| 8-K | — | 2023-01-19 | — | |
| 8-K | — | 2022-11-29 | — | |
| 10-Q | — | 2022-11-09 | 2022-09-30 | |
| 8-K | — | 2022-11-02 | — | |
| 8-K | — | 2022-08-19 | 2022-08-17 | |
| 8-K | — | 2022-08-01 | 2022-07-22 | |
| 10-Q | — | 2022-08-01 | 2022-06-30 | |
| 8-K | — | 2022-05-31 | — | |
| 10-Q | — | 2022-05-09 | 2022-03-31 | |
| 8-K | — | 2022-05-04 | — | |
| DEF 14A | — | 2022-04-28 | 2022-05-24 | |
| 8-K | — | 2022-04-26 | 2022-04-22 | |
| 10-K | — | 2022-03-18 | 2021-12-31 | |
| 8-K | — | 2022-02-25 | 2022-02-22 | |
| 8-K | — | 2022-01-20 | — | |
| 8-K | — | 2021-12-21 | 2021-12-20 | |
| 10-Q | — | 2021-11-12 | 2021-09-30 | |
| 8-K | — | 2021-11-03 | 2021-11-01 | |
| 8-K | — | 2021-11-01 | — | |
| 8-K | — | 2021-10-08 | — | |
| 10-Q | — | 2021-08-16 | 2021-06-30 | |
| 8-K/A | — | 2021-08-05 | 2021-06-25 | |
| 8-K | — | 2021-06-30 | 2021-06-25 | |
| 8-K | — | 2021-06-04 | 2021-06-03 | |
| 8-K | — | 2021-05-13 | — | |
| 10-Q | — | 2021-04-30 | 2021-03-31 | |
| DEF 14A | — | 2021-04-29 | 2021-06-03 | |
| 8-K | — | 2021-04-19 | 2021-04-14 | |
| 10-K | — | 2021-03-05 | 2020-12-31 | |
| 8-K | — | 2020-12-17 | 2020-12-12 | |
| 10-Q | — | 2020-11-09 | 2020-09-30 | |
| 8-K | — | 2020-09-15 | 2020-09-10 | |
| 10-Q | — | 2020-08-13 | 2020-06-30 | |
| 8-K/A | — | 2020-07-31 | 2020-06-17 | |
| 8-K | — | 2020-06-23 | 2020-06-17 | |
| 10-K | — | 2020-06-08 | 2020-03-31 | |
| 10-Q | — | 2020-02-14 | 2019-12-31 |
Showing 51–92 of 92 filings
Key facts
CIK
1738021
CUSIP
20454B104
13F (30d)
10 filings
10 filers
Visit website
Investor relations